ATRC - AtriCure Inc

AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems to medical centers in the United States, Europe, Asia, and internationally. The company is headquartered in Mason, Ohio.

52W High

$43.11

52W Low

$25.57

MA Status:

50D: Above 200D: Above

Beta (~1 neutral, <0.9 lower risk)

1.62

Valuation

As of 2025-06-30 (Overview)

Trailing P/E (<15 better)

N/A

Forward P/E (<15 better)

N/A

EV/EBITDA (<8 favorable)

-135.97

EV/Revenue (<3 favorable)

3.44

P/S (TTM) (<3 favorable)

3.52

P/B (<3 favorable)

3.79

Ownership

Institution‑heavy

Source: Overview

Insiders (1–5% typical)

3.23%

Institutions (25–75% balanced)

100.59%

Shares Outstanding

49,701,400

Float

47,931,100

Dividend Yield (2–6% sweet spot)

N/A

Ex‑Dividend Date

N/A

Income & Growth

Profitability: Weak

As of 2025-06-30 (Overview)

Revenue (TTM)

499,946,000

Gross Profit (TTM)

373,522,000

EPS (TTM)

-0.77

Profit Margin (>10% good)

-0.07%

Operating Margin (TTM) (higher better)

-0.05%

ROE (TTM) (>15% strong)

-0.08%

EPS YoY (Quarterly) (>10% good)

N/A

Revenue YoY (Quarterly) (>8% good)

0.17

Momentum

Bearish momentum

Value

0.4358

0.2797

Trend

Rising

Signal Cross

No cross

As of

Sep. 11, 2025